Left Ventricular Assist Devices (LVAD)

The HeartMate II™ LVAD is designed to provide short-term or long-term circulatory support for patients with advanced heart failure and is indicated in the United States for both target therapy and bridge to transplantation. Backed by over 10 years of data, the HeartMate II LVAD is the most widely used and most extensively studied LVAD in the world, implanted in more than 27,000 patients worldwide.